These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17191217)

  • 1. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
    Pontiki E; Hadjipavlou-Litina D
    Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
    Eleni P; Dimitra HL
    Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
    Choudhary AN; Kumar A; Juyal V
    Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
    Kontogiorgis CA; Hadjipavlou-Litina D
    Med Res Rev; 2004 Nov; 24(6):687-747. PubMed ID: 15250038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
    Kontogiorgis CA; Hadjipavlou-Litina D
    Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
    Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
    Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcones in cancer: understanding their role in terms of QSAR.
    Katsori AM; Hadjipavlou-Litina D
    Curr Med Chem; 2009; 16(9):1062-81. PubMed ID: 19275612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalcones in cancer: understanding their role in terms of QSAR. II part.
    Repanas A; Katsori AM; Hadjipavlou-Litina D
    Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure.
    Kuhn H; Saam J; Eibach S; Holzhütter HG; Ivanov I; Walther M
    Biochem Biophys Res Commun; 2005 Dec; 338(1):93-101. PubMed ID: 16168952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic.
    Camargo AB; Marchevsky E; Luco JM
    J Agric Food Chem; 2007 Apr; 55(8):3096-103. PubMed ID: 17367159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
    Hansch C; Verma RP
    Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
    Pontiki E; Hadjipavlou-Litina D
    Med Res Rev; 2012 Jan; 32(1):1-165. PubMed ID: 20162725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
    Payne AN; Jackson WP; Salmon JA; Nicholls A; Yeadon M; Garland LG
    Agents Actions Suppl; 1991; 34():189-99. PubMed ID: 1793063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary alkyl hydroperoxides as inhibitors and alternate substrates for lipoxygenase.
    Waller TM; Decker I; Frisch JP; Kernstock RM; Kim YW; Funk MO
    Biochemistry; 2008 Jan; 47(1):331-8. PubMed ID: 18067328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Approach towards the quantitative structure-activity relationships of caffeic acid and its derivatives.
    Verma RP; Hansch C
    Chembiochem; 2004 Sep; 5(9):1188-95. PubMed ID: 15368569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel ketoprofen amides--synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents.
    Rajić Z; Hadjipavlou-Litina D; Pontiki E; Kralj M; Suman L; Zorc B
    Chem Biol Drug Des; 2010 Jun; 75(6):641-52. PubMed ID: 20337784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
    Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P
    Bioorg Med Chem; 2009 Dec; 17(23):8073-85. PubMed ID: 19853459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR models on H
    Pontiki E; Hadjipavlou-Litina D
    J Biomol Struct Dyn; 2017 Apr; 35(5):968-1005. PubMed ID: 26982393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
    Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
    Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.